Skip to main navigation

Our Company
Our Focus
- Overview
- Neuroblastoma
- CNS/LM
- Osteosarcoma
- DIPG
- Medulloblastoma
- DSRCT
Our Research & Development
Our Patient & Family Support
- Overview
- Access to Clinical Trials
For Medical Professionals
- Overview
- Clinical Trials
For Investors

Events

Events

Investor Relations
Events

Upcoming Events

May 8, 2024 at 8:00 AM EDT

First Quarter 2023 Financial and Operating Results

Past Events

Mar 1, 2024 at 8:00 AM EST

Fourth Quarter 2023 Financial and Operating Results

Jan 10, 2024 at 5:15 PM PST

42nd Annual J.P. Morgan Healthcare Conference

Ymabs - Toolkit

Print Page
Email Alerts
RSS Feeds

Privacy Statement

Terms of Use

Contact Us

References

© 2024 Y-mAbs Therapeutics, Inc. All rights reserved.
YMB0007_GB_v1

You are leaving this website

You are about to leave ymabs.com. The link will take you to a website that may be maintained by a third party, which is solely responsible for its content. Y-mAbs Therapeutics, Inc provides this link as a service to its web visitors, and is not responsible for the privacy policy or terms of use of any third-party website.

Close Continue